Inhibitory antibodies identify unique sites of therapeutic vulnerability in rhinovirus and other enteroviruses.
Meng, B., Lan, K., Xie, J., Lerner, R.A., Wilson, I.A., Yang, B.(2020) Proc Natl Acad Sci U S A 117: 13499-13508
- PubMed: 32467165 
- DOI: 10.1073/pnas.1918844117
- Primary Citation of Related Structures:  
6KYZ, 6KZ0 - PubMed Abstract: 
The existence of multiple serotypes renders vaccine development challenging for most viruses in the Enterovirus genus. An alternative and potentially more viable strategy for control of these viruses is to develop broad-spectrum antivirals by targeting highly conserved proteins that are indispensable for the virus life cycle, such as the 3C protease ...